Sofinnova Investments, Inc. Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$1.7T
Holdings
66
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (66 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera | 3,100,560 | $308.6B | 18.37% | |
| 2 | KRTXKaruna Therapeutics, Inc. | 1,952,441 | $198.3B | 11.81% | |
| 3 | ASNDAscendis Pharma A/S | 1,109,874 | $185.1B | 11.02% | |
| 4 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $108.6B | 6.47% | |
| 5 | UTHUnited Therapeutics Corp | 347,901 | $52.8B | 3.14% | |
| 6 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $52.6B | 3.13% | |
| 7 | AZNAstraZeneca PLC | 842,600 | $42.1B | 2.51% | |
| 8 | INZYInozyme Pharma, Inc. | 2,028,308 | $41.9B | 2.49% | |
| 9 | AMGNAmgen Inc | 164,663 | $37.9B | 2.25% | |
| 10 | JAZZJazz Pharmaceuticals PLC | 212,911 | $35.1B | 2.09% | |
| 11 | XLVHealth Care Select Sector SPDR | 300,000 | $34.0B | 2.03% | Put |
| 12 | GRTXGalera Therapeutics, Inc | 3,083,712 | $31.5B | 1.88% | |
| 13 | ABBVAbbvie Inc | 293,596 | $31.5B | 1.87% | |
| 14 | —Akouos, Inc | 1,515,074 | $30.0B | 1.79% | |
| 15 | —Nextcure, Inc | 2,671,856 | $29.1B | 1.73% | |
| 16 | ITCIEURIntra-Cellular Therapies Inc | 848,162 | $27.0B | 1.61% | |
| 17 | IWMiShares Russell 2000 ETF | 130,000 | $25.5B | 1.52% | Put |
| 18 | —Nucana Biomed Ltd | 5,599,999 | $25.1B | 1.50% | |
| 19 | MRUSMerus N.V. | 1,311,039 | $23.0B | 1.37% | |
| 20 | PTCTPTC Therapeutics Inc | 316,478 | $19.3B | 1.15% | |
| 21 | RETAEURReata Pharmaceuticals Inc | 148,937 | $18.4B | 1.10% | |
| 22 | —Athira Pharma, Inc. | 509,168 | $17.4B | 1.04% | |
| 23 | OTICEUROtonomy Inc | 2,620,668 | $17.0B | 1.01% | |
| 24 | HZNPHorizon Therapeutics PLC | 213,390 | $15.6B | 0.93% | |
| 25 | PTGXProtagonist Therapeutics Inc | 724,904 | $14.6B | 0.87% | |
| 26 | BMRNBiomarin Pharmaceutical Inc | 164,545 | $14.4B | 0.86% | |
| 27 | ACRSAclaris Therapeutics | 1,911,573 | $12.4B | 0.74% | |
| 28 | RGNXRegenxbio Inc | 271,114 | $12.3B | 0.73% | |
| 29 | —GW Pharmaceuticals PLC | 100,762 | $11.6B | 0.69% | |
| 30 | —Nucana Biomed Ltd | 2,400,000 | $10.8B | 0.64% | |
| 31 | CYTKCytokinetics Inc | 508,394 | $10.6B | 0.63% | |
| 32 | MGNXMacroGenics Inc | 458,807 | $10.5B | 0.62% | |
| 33 | —TCR2 Therapeutics Inc | 333,707 | $10.3B | 0.61% | |
| 34 | IM8NInsmed Inc | 309,662 | $10.3B | 0.61% | |
| 35 | —ObsEva SA | 4,749,623 | $9.9B | 0.59% | |
| 36 | ARNAEURArena Pharmaceuticals Inc | 121,373 | $9.3B | 0.56% | |
| 37 | SRPTSarepta Therapeutics Inc | 51,848 | $8.8B | 0.53% | |
| 38 | ACADACADIA Pharmaceuticals Inc | 164,625 | $8.8B | 0.52% | |
| 39 | BCRXBioCryst Pharmaceuticals Inc | 1,122,800 | $8.4B | 0.50% | |
| 40 | SNDXSyndax Pharmaceuticals Inc | 372,909 | $8.3B | 0.49% | |
| 41 | MIRMMirum Pharmaceuticals Inc | 454,974 | $7.9B | 0.47% | |
| 42 | CHRSCoherus BioSciences | 434,555 | $7.6B | 0.45% | |
| 43 | CCXIEURChemoCentryx Inc | 113,213 | $7.0B | 0.42% | |
| 44 | JNCEEURJounce Therapeutics Inc | 925,280 | $6.5B | 0.39% | |
| 45 | PBYIPuma Biotechnology Inc | 629,650 | $6.5B | 0.38% | |
| 46 | LLYEli Lilly and Co | 36,909 | $6.2B | 0.37% | |
| 47 | AMRNAmarin Corp | 1,170,584 | $5.7B | 0.34% | |
| 48 | ALGSAligos Therapeutics Inc | 191,061 | $5.3B | 0.31% | |
| 49 | —Calithera Biosciences Inc | 1,075,326 | $5.3B | 0.31% | Put |
| 50 | RCUSArcus Biosciences Inc | 186,278 | $4.8B | 0.29% | |
| 51 | XLRNAcceleron Pharma Inc | 36,688 | $4.7B | 0.28% | |
| 52 | IOVAIovance Biotherapeutics Inc | 100,000 | $4.6B | 0.28% | Put |
| 53 | —Aptose Biosciences Inc | 981,135 | $4.3B | 0.26% | |
| 54 | 1K0IGM Biosciences Inc | 45,131 | $4.0B | 0.24% | |
| 55 | KURAKura Oncology Inc | 120,677 | $3.9B | 0.23% | |
| 56 | TGTXTG Therapeutics Inc | 65,474 | $3.4B | 0.20% | |
| 57 | MRNS*Marinus Pharmaceuticals Inc | 274,027 | $3.3B | 0.20% | |
| 58 | IMTXImmatics NV | 279,532 | $3.0B | 0.18% | |
| 59 | —Zogenix Inc | 89,579 | $1.8B | 0.11% | |
| 60 | —Synlogic Inc. | 574,972 | $1.2B | 0.07% | |
| 61 | FATEFate Therapeutics Inc | 13,497 | $1.2B | 0.07% | |
| 62 | —Kadmon Holdings Inc | 228,893 | $950.0M | 0.06% | |
| 63 | REPLReplimune Group Inc | 20,000 | $763.0M | 0.05% | |
| 64 | LQDALiquidia Corp | 147,744 | $436.0M | 0.03% | |
| 65 | PDSBPDS Biotechnology Corporation | 142,635 | $305.0M | 0.02% | |
| 66 | BCABBioatla Inc | 3,000 | $102.0M | 0.01% |